Molecule Name |
DB09236
|
DrugBank Groups |
Approved
|
Cluster No |
211
|
Smiles |
O=C(OCC)C1(=C(NC(C)=C(C1C2(=C(C=CC=C2)C=CC(=O)OC(C)(C)C))C(=O)OCC)C)
|
Download |
mol2, pdbqt
|
TPSA |
90,93
|
Non-H Atoms |
33
|
Non-C/H Atoms |
7
|
Metal-Atoms |
0
|
Electronegative Atoms |
7
|
Stereo Centers |
0
|
Rotatable Bonds |
11
|
Rings Closures |
2
|
Small Rings |
2
|
Aromatic Rings |
1
|
Aromatic Atoms |
6
|
sp3-Atoms |
14
|
Symmetric atoms |
10
|
cLogS |
-4,67
|
MW |
455,549
|
cLogP |
4,6767
|
HBA |
7
|
HBD |
1
|
Ro5 violations |
0
|
Druglikeness |
-24,544
|
DrugScore |
0,254668115349003
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB-
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-4,033
|
Caco-2 Permeability 2 |
1,3486
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Inhibitor
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
0,0943
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,8691
|
Honey Bee Toxicity |
High HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,4198
|
Carcinogenicity (Three-class) |
Non-required
|